1. A novel biomarker GATM suppresses proliferation and malignancy of cholangiocarcinoma cells by modulating the JNK/c-Jun signalling pathways
   Yi Yu et al, 2024, Heliyon CrossRef
2. Anticancer agents and genetic identification of Pterospermum , an indigenous plant of Sarawak, Malaysia
   Anthony Nyangson Steven et al, 2024, Journal of Taibah University for Science CrossRef
3. FGF2-mediated attenuation of myofibroblast activation is modulated by distinct MAPK signaling pathways in human dermal fibroblasts
   David M. Dolivo et al, 2017, Journal of Dermatological Science CrossRef
4. Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma
   Lesley Jia Wei Pua et al, 2022, International Journal of Molecular Sciences CrossRef
5. L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating KRAS Mutation
   Haejung Kim et al, 2017, Molecules and Cells CrossRef
6. Inhibition on JNK Mimics Silencing of Wnt-11 Mediated Cellular Response in Androgen-Independent Prostate Cancer Cells
   Elif Damla Arisan et al, 2020, Biology CrossRef
7. Advantages and drawbacks of dexamethasone in glioblastoma multiforme
   Amir R. Afshari et al, 2022, Critical Reviews in Oncology/Hematology CrossRef
8. JNK, p38, ERK, and SGK1 Inhibitors in Cancer
   Jonas Cicenas et al, 2017, Cancers CrossRef
9. Network analysis of genes involved in the enhancement of hyperthermia sensitivity by the knockdown of BAG3 in human oral squamous cell carcinoma cells
   TATSUYA YUNOKI et al, 2016, International Journal of Molecular Medicine CrossRef
10. Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link
    Chaobo Chen et al, 2019, Cells CrossRef
11. Neuroprotection effect of Y-27632 against H2O2-induced cell apoptosis of primary cultured cortical neurons
    Xingqin Wang et al, 2016, RSC Advances CrossRef
12. Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma
    Panagiotis Papoutsoglou et al, 2019, Cells CrossRef
13. Exploring Dysregulated Signaling Pathways in Cancer
    Sabah Nisar et al, 2020, Current Pharmaceutical Design CrossRef
14. Role of Smad signaling in kidney disease
    Yanhua Zhang et al, 2015, International Urology and Nephrology CrossRef
15. Inflammation and Cancer Development in Pancreatic and Biliary Tract Cancer
    Sang Hoon Lee et al, 2015, The Korean Journal of Gastroenterology CrossRef
16. Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors
    Farhana Runa et al, 2024, Pharmaceuticals CrossRef
17. MAPK signaling pathways in eye wounds: Multifunction and cooperation
    Boyuan Yao et al, 2017, Experimental Cell Research CrossRef
18. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
    Pengfei Qiao et al, 2015, BMC Cancer CrossRef
19. JNK Contributes to the Tumorigenic Potential of Human Cholangiocarcinoma Cells through the mTOR Pathway Regulated GRP78 Induction
    Chunhong Feng et al, 2014, PLoS ONE CrossRef